Akagera Medicines Reports Positive Phase 1 AKG-100 Results
KIGALI, Rwanda, July 20, 2026 Akagera Medicines, Inc. has announced positive first-in-human Phase 1 results for AKG-100, its investigational...
Phase 1 trial
Advertisement
Innate Pharma Reaches Phase 1 Enrollment Milestone for IPH4502
Marseille, France | July 21, 2026 Innate Pharma SA has announced the completion of enrollment in the dose-escalation portion...
Immunome Doses First Patient in Phase 1 IM-3050 Radioligand Therapy Trial
BOTHELL, Wash., July 20, 2026 Immunome, Inc. (Nasdaq: IMNM) announced that the first patient has been dosed in the...
GSK Seeks EMA Approval for Bexsero Booster Vaccine Update
LONDON, United Kingdom, July 20, 2026 GSK plc has announced that the European Medicines Agency (EMA) has accepted its...
BioLineRx to Present GLIX1 Ovarian Cancer Data at ESMO 2026
TEL AVIV, Israel & OSLO, Norway, July 20, 2026 BioLineRx Ltd. and Hemispherian AS have announced that new preclinical...
Advertisements
Xencor Shares Kidney Cancer Trial Results at ESMO
PASADENA, Calif., July 17, 2026 Xencor, Inc. announced that Phase 1 clinical results for XmAb819, its investigational ENPP3 ×...
Bambusa Reports Promising BBT002 Data for COPD Therapy
BOSTON, June 15, 2026 Bambusa Therapeutics has announced positive preliminary multiple ascending dose (MAD) Phase 1 clinical data for...
GSK Completes Nuvalent Acquisition to Expand Lung Cancer
LONDON, July 16, 2026 GSK plc has officially completed its acquisition of Nuvalent, Inc., marking a major strategic expansion...
Moderna Doses First Patient in mRNA-4200 Cancer Trial
CAMBRIDGE, Mass., July 16, 2026 Moderna, Inc. has announced the first participant has been dosed in its Phase 1...
Kairos Announces Positive Interim Phase 1 ENV-105 Data
LOS ANGELES, July 15, 2026 Kairos Pharma announced encouraging interim safety results from its ongoing Phase 1 clinical trial...
Advertisement
